Several studies have described potential microRNA (miRNA) biomarkers associated with migraine, but studies are scarcely reproducible primarily due to the heterogeneous variability of partici...
The response to cluster headache treatments has a high interindividual variation. To date, treatment response has only been assessed by candidate gene approach and no investigations into met...
To prospectively assess the efficacy and safety of fremanezumab for migraine prophylaxis in patients with failure of at least three previous preventive treatments. Changes in disability as a...
For many years triptans have been the cornerstone of acute migraine treatment. Nevertheless, treatment with triptans may not always be initiated due to contraindications (seen in approximat...
Headache is among the most common comorbidities in epilepsy. This study examined the distribution of different primary headache disorders in a large cohort of patients with diagnosed epileps...
Although several recent studies have attempted to describe the association between psoriasis and migraine, there is little data in this regard.To explore the relationship between migraine an...
Several tribal medicinal systems assert anti-migraine and common headache-remedying properties in all parts of (L.f.) Druce. Therefore, there are no clear scientific references to the valid...
Migraine is a primary headache disorder. Studies have shown that 93% of people with migraine have an increased number of active myofascial trigger points (MTrPs).To examine the effects of th...
Cortical spreading depolarization (CSD) is the neuronal correlate of migraine aura and the reliable consequence of acute brain injury. The role of CSD in triggering headaches that follow mig...
Migraine is a common neurovascular disorder characterized by recurrent episodes of headache and associated neurological symptoms. At present, a significant portion of patients do not obtain ...
To evaluate the efficacy and safety of galcanezumab in patients with migraine in a real-world setting in Japan.Galcanezumab is the first anti-calcitonin gene-related peptide monoclonal antib...
To compare clinical features in youth with continuous headache from migraine, persistent post-traumatic headache, and new daily persistent headache to determine if they are similar, contrary...
Migraine is a type of primary headache caused by changes in the trigeminal system and has been reported to be associated with neurovascular inflammation of cerebral and extracerebral vessels...
Dementia is an urgent public health problem worldwide, and the determination of the contribution of pain to cognitive decline or dementia is significant for the prevention of dementia.To com...
Chronic migraine (CM) patients who report a high frequency and intensity of headaches also report neck pain (NP) and neck disability (ND) in neck activities that require stability. In this c...
(1) Background: To assess the time trend in the prevalence of chronic neck pain (CNP), chronic low back pain (CLBP), and migraine or frequent headache (MFH) among people with diabetes in Spa...
The multinational phase 3b DELIVER trial was designed to evaluate the efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures across 1...
Caffeine consumption is a risk factor for chronic daily headache, but few studies have addressed relationships between pediatric patient caffeine levels and headache severity. We examined as...
For patients with migraine, poor sleep quality contributes to increased migraine risk and migraine pain, as well as reduced QOL and mental health. Migraine has been shown to significa...
A study on the indirect costs of migraine in a large school district shows that the greatest costs are associated with absenteeism and productivity. “We know from real-world experie...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
